Covina, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Cell therapy and gene therapy are fields of biomedical research and treatment, both therapies aim to treat, prevent, or potentially cure diseases, and both methods have the potential to address the underlying cause of genetic and acquired diseases. Cell and gene therapies provide significant advances in patient care by treating or possibly curing a variety of diseases that were previously untreatable by small molecule and biological drugs.  Specifically, gene therapy uses genetic material, or DNA, to manipulate a patient's cells to treat an inherited or acquired disease. Cell therapy is the infusion or transplantation of whole cells into a patient to treat an inherited or acquired disease. After decades of effort, the future of gene and cell therapy is incredibly promising, with recent breakthroughs that have led to the approval of many life-changing treatments for patients and many products in development. Gene therapy replaces a faulty gene or adds a new gene in an attempt to cure a disease or improve your body's ability to fight disease. Gene therapy holds promise for treating a wide range of diseases such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia and AIDS. Potential applications of cell therapy include treating cancer, autoimmune diseases, urinary problems and infectious diseases, repairing damaged joints, repairing spinal cord injuries, improving weakened immune systems, and helping patients with neurological disorders. Gene therapy is being used to treat many diseases, including an eye disorder called Leber congenital amaurosis and a muscle disorder called spinal muscular atrophy, with many gene therapies being researched to ensure they are safe and effective. Gene therapy is a technique that modifies a person's genes to treat or cure a disease, gene therapies can work through several mechanisms; a healthy copy of the gene replaces the disease-causing gene. The cell and gene therapy product market was dominated by the cell therapy product sector. Cellular therapy products include hematopoietic stem cells and adult and embryonic stem cells for certain therapeutic indications, including cellular immunotherapy, cancer vaccines, and both autologous and allogeneic cell types. This growth is attributed to a significant number of active clinical trials as well as an increase in the number of products coming to market. The major factor driving the cell and gene therapy market is the increased pool of patients with various diseases, product launches and approvals. Also, favorable regulatory support for cell and gene therapy products and specialty designations, increasing demand for car T-cell therapy products. The market is expected to grow at a significant growth rate due to opportunities in its domain which include drug approvals and a strong pipeline of cell and gene therapy. Increasing prevalence of cardiovascular disease is expected to drive the cell and gene therapy market over the forecast period.

The report "Cell and Gene Therapy Market, By Products (Cell Therapy, and Gene Therapy), By Distribution Channel Type (Oncology, Dermatology, Musculoskeletal, and Others), By End-Users (Hospitals, Wound Care Centers, Cancer Care Centers, Ambulatory Surgical Centers, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends Analysis and Forecast till 2032"

Key Highlights:

• In December 2022, by partnering with clinical-stage Arcellx, Gilead Sciences has the opportunity to develop a cell therapy for mulple myeloma that may offer advantages over currently available treatments for blood cancers. The deal, announced in December, comes after Arcellx reported additional data at the American Society of Hematology's annual meeting that showed the cell therapy's durability.
• In June 2022, Jacobs was hired by Spark Therapeutics, Inc. to build a gene therapy innovation center in the University City area of West Philadelphia. Engineering procurement and construction management contracts were also awarded. Upon completion, the multistory facility will serve as a global hub for gene therapy manufacturing and advancing the science of gene therapy.
• In January 2022, Amgen and Generate Biomedicine announced a research collaboration agreement to discover and develop protein therapeutics for five clinical targets across multiple therapeutic areas and multiple modalities.
• In June 2021, Dendreon Pharmaceuticals announced that it had formed a contract manufacturing and services division to develop late-stage clinical candidates through commercialization, the company said it will be able to offer end-to-end manufacturing of cell therapies for its clients.

Analyst View:

Cell and gene therapy plays a major role in modern health care, as it provides concepts and techniques that can be used in gene regulation, cell-cell interactions, regenerative capacity, and remodeling. Cell therapy and gene therapy are fields of biomedical research and treatment, both therapies aim to treat, prevent, or potentially cure disease, and both methods have the potential to address the underlying cause of genetic and  the acquired diseases. Cell and gene therapies offer significant advances in patient care by helping to treat or potentially cure a range of conditions untouched by small molecules and biologic agents. Innovation in the cell and gene therapy market is increasing worldwide, driven by technological developments in cell and gene therapy that are more efficient to use.

Request Free Sample Copy: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4053

 Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on "Cell and Gene Therapy Market, By Products (Cell Therapy, and Gene Therapy), By Distribution Channel Type (Oncology, Dermatology, Musculoskeletal, and Others), By End-Users (Hospitals, Wound Care Centers, Cancer Care Centers, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032"

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Cell-and-Gene-Therapy-4053

Key Market Insights from the report:

Cell and Gene Therapy Market accounted for US$ 13.0 billion in 2022 and is estimated to be US$ 62.5 billion by 2032 and is anticipated to register a CAGR of 22.8%. The Cell and Gene Therapy Market is segmented based on Application, Property and Region.

• Based on Products, Cell and Gene Therapy Market is segmented into Cell Therapy, and Gene Therapy.
• Based on Distribution Channel Type, Cell and Gene Therapy Market is segmented into Oncology, Dermatology, Musculoskeletal, and Others.
• Based on End Users, Cell and Gene Therapy Market is segmented into Hospitals, Wound Care Centers, Cancer Care Centers, Ambulatory Surgical Centers, and Others.
• By Region, the Cell and Gene Therapy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Cell and Gene Therapy Market:

The prominent players operating in the Cell and Gene Therapy Market includes, Gilead Sciences, Spark Therapeutics, Novartis AG, Organogenesis, Amgen, Osiris Therapeutics, Dendreon, Vericel, Anterogen, Tego Sciences. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Scope of the Report: 

1. Global Cell and Gene Therapy Market, By Products, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Cell Therapy
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Gene Therapy
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
2. Global Cell and Gene Therapy Market, Distribution Channel Products, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Oncology
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Dermatology]
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Musculoskeletal
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
3. Global Cell and Gene Therapy Market, By End-Users, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Hospitals
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Wound Care Centers
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Care Centers
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Ambulatory Surgical Centers
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Request Cutomization: https://www.prophecymarketinsights.com/market_insight/Insight/request-customization/4053

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

• Explains an overview of the product portfolio, including product development, planning, and positioning
• Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
• Detailed analysis of the market revenue over the forecasted period.
• Examining various outlooks of the market with the help of Porter's five forces analysis, PEST & SWOT Analysis.
• Study on the segments that are anticipated to dominate the market.
• Study on the regional analysis that is expected to register the highest growth over the forecast period

Browse Realted Reports: 

1. Gene Therapy Market, By Gene Therapy Type (Germline Gene Therapy and Somatic Gene Therapy), By Type of Vector (Viral Vector and Non-viral Vector), By Disease Indication (Cardio Vascular Diseases, Cancer, Genetic Disorders, Neuro Disorders, Infectious Diseases, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

2. Personalized Gene Therapy Treatment Market, By Therapy (Targeted Treatments and Pharmacogenomics), By Application (Breast Cancer, Brain Cancer, Colorectal Cancer, Certain Childhood Cancers, Gastrointestinal Stromal Tumor, Kidney Cancer, Leukemia, Lymphoma, Melanoma, Lung Cancer, and Multiple Myeloma)and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029

3. Gene Therapy for Rare Disease Market By Drug (Approved Drugs (Tisagenlecleucel (Kymriah), Axicabtagene ciloleucel (Yescarta), Voretigene neparvovec (Luxturna), and Strimvelis), Pipeline Drugs (GT-AADC, Fidanacogene elaparvovec (SPK-9011), OTL-200, bb2121, AMT-061, and Others), By Therapeutic Application (Oncology, Neurological Disorders, Ophthalmic Disorders, Hematological Disorders, Immunodeficiency Disorders, Metabolic Disorders, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Trends, Analysis and Forecast till 2029

Kunal D
Prophecy Market Insights
U.S.: +1 860 531 2701
APAC: +917775049802
Email- sales@prophecymarketinsights.com
Web: www.prophecymarketinsights.com